The U.S. diabetes epidemic affects millions, with 1.4 million new cases diagnosed each year. Today, more than 30 million Americans are living with diabetes, including 7 million who are unaware they have the disease. For many patients, a diabetes diagnosis affects nearly every aspect of life, including special dietary concerns and other lifestyle changes, as well as daily medicines to help manage their blood glucose levels.
America’s biopharmaceutical researchers are persistent in their efforts to develop novel therapies to treat this complex and challenging illness and to improve the quality of life for patients. Today, there are 171 medicines in development for type 1 and type 2 diabetes and diabetes-related conditions, such as chronic kidney disease and diabetic neuropathy. All of these medicines are in clinical trials or awaiting review by the U.S. Food and Drug Administration. Biopharmaceutical researchers are tirelessly working to find new lifesaving and life-changing treatments and cures to address this complex disease and the costs associated with it.